127 related articles for article (PubMed ID: 23618529)
21. Inhibition of FOXO1/3 promotes vascular calcification.
Deng L; Huang L; Sun Y; Heath JM; Wu H; Chen Y
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):175-83. PubMed ID: 25378413
[TBL] [Abstract][Full Text] [Related]
22. MHY-449, a novel dihydrobenzofuro[4,5-b][1,8] naphthyridin-6-one derivative, induces apoptotic cell death through modulation of Akt/FoxO1 and ERK signaling in PC3 human prostate cancer cells.
Lee SH; Kang YJ; Sung B; Kim DH; Lim HS; Kim HR; Kim SJ; Yoon JH; Moon HR; Chung HY; Kim ND
Int J Oncol; 2014 Mar; 44(3):905-11. PubMed ID: 24424889
[TBL] [Abstract][Full Text] [Related]
23. Taiwan cobra cardiotoxin III inhibits Src kinase leading to apoptosis and cell cycle arrest of oral squamous cell carcinoma Ca9-22 cells.
Chien CM; Chang SY; Lin KL; Chiu CC; Chang LS; Lin SR
Toxicon; 2010 Sep; 56(4):508-20. PubMed ID: 20493203
[TBL] [Abstract][Full Text] [Related]
24. Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling.
Chen HJ; Lin CM; Lee CY; Shih NC; Amagaya S; Lin YC; Yang JS
Int J Oncol; 2013 Aug; 43(2):629-37. PubMed ID: 23754208
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor-induced cell death and radiosensitization in epidermal growth factor receptor-overexpressing cancer cell lines.
Kim K; Wu HG; Jeon SR
Anticancer Res; 2015 Jan; 35(1):245-53. PubMed ID: 25550557
[TBL] [Abstract][Full Text] [Related]
26. The in vitro and in vivo anti-tumor effect of KO-202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer.
Oh M; Lee JY; Shin DH; Park JH; Oian T; Kim HJ; Cho SD; Oh SH; Min YK; Kong G
Cancer Sci; 2011 Mar; 102(3):597-604. PubMed ID: 21205071
[TBL] [Abstract][Full Text] [Related]
27. Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.
Kyo S; Sakaguchi J; Kiyono T; Shimizu Y; Maida Y; Mizumoto Y; Mori N; Nakamura M; Takakura M; Miyake K; Sakamoto M; Inoue M
Clin Cancer Res; 2011 Feb; 17(3):525-37. PubMed ID: 21131554
[TBL] [Abstract][Full Text] [Related]
28. Chemopreventive effect of quercetin, a natural dietary flavonoid on prostate cancer in in vivo model.
Sharmila G; Bhat FA; Arunkumar R; Elumalai P; Raja Singh P; Senthilkumar K; Arunakaran J
Clin Nutr; 2014 Aug; 33(4):718-26. PubMed ID: 24080313
[TBL] [Abstract][Full Text] [Related]
29. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of FoxO1 nuclear exclusion prevents metastasis of glioblastoma.
Chen J; Huang Q; Wang F
Tumour Biol; 2014 Jul; 35(7):7195-200. PubMed ID: 24771221
[TBL] [Abstract][Full Text] [Related]
31. Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations.
Yeh YT; Yeh H; Su SH; Lin JS; Lee KJ; Shyu HW; Chen ZF; Huang SY; Su SJ
Free Radic Biol Med; 2014 Sep; 74():1-13. PubMed ID: 24952138
[TBL] [Abstract][Full Text] [Related]
32. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
[TBL] [Abstract][Full Text] [Related]
33. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
[TBL] [Abstract][Full Text] [Related]
34. LRP16 gene protects mouse insulinoma MIN6 cells against fatty acid-induced apoptosis through Akt/FoxO1 signaling.
Li XJ; Guo QH; Wang X; Xue B; Sun LQ; Meng QT; Lu JM; Mu YM
Chin Med J (Engl); 2012 May; 125(10):1695-702. PubMed ID: 22800886
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of H2O2-induced cell death through FOXO1 modulation by EUK-172 in SK-N-MC cells.
Gheysarzadeh A; Yazdanparast R
Eur J Pharmacol; 2012 Dec; 697(1-3):47-52. PubMed ID: 23041154
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
[TBL] [Abstract][Full Text] [Related]
37. Gefitinib, a selective EGFR tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cells.
Ariyama H; Qin B; Baba E; Tanaka R; Mitsugi K; Harada M; Nakano S
J Cell Biochem; 2006 Mar; 97(4):724-34. PubMed ID: 16229013
[TBL] [Abstract][Full Text] [Related]
38. Lupeol evokes anticancer effects in oral squamous cell carcinoma by inhibiting oncogenic EGFR pathway.
Rauth S; Ray S; Bhattacharyya S; Mehrotra DG; Alam N; Mondal G; Nath P; Roy A; Biswas J; Murmu N
Mol Cell Biochem; 2016 Jun; 417(1-2):97-110. PubMed ID: 27206736
[TBL] [Abstract][Full Text] [Related]
39. Helioxanthin suppresses the cross talk of COX-2/PGE2 and EGFR/ERK pathway to inhibit Arecoline-induced Oral Cancer Cell (T28) proliferation and blocks tumor growth in xenografted nude mice.
Lin YM; Kuo WW; Velmurugan BK; Hsien HH; Hsieh YL; Hsu HH; Tu CC; Bau DT; Viswanadha VP; Huang CY
Environ Toxicol; 2016 Dec; 31(12):2045-2056. PubMed ID: 26464283
[TBL] [Abstract][Full Text] [Related]
40. Lewisy promotes migration of oral cancer cells by glycosylation of epidermal growth factor receptor.
Lin WL; Lin YS; Shi GY; Chang CF; Wu HL
PLoS One; 2015; 10(3):e0120162. PubMed ID: 25799278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
